Characteristics of long-term survivors of untreated lung cancer

Lung Cancer

Volumn 36, Issue 3, 2002, Pages 277-282

  Mattern, Jürgen ^a   Koomägi, Reet ^a   Volm, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; Lung cancer; Prognosis; Tumor cell proliferation; Tumor growth

Indexed keywords

CYCLIN A; EPIDERMAL GROWTH FACTOR RECEPTOR; FAS ANTIGEN; PROTEIN; PROTEIN BCL 2; PROTEIN FOS; PROTEIN JUN; PROTEIN P53; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; LUNG CANCER; MALE; ONCOGENE; ONCOGENE RAS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RANK SUM TEST;

APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK FACTORS; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036253412     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00010-7     Document Type: Article

References (41)

1. Prognostic factors in non-small cell lung cancer
2. Prognostic factors in resected non-small cell lung cancer: An immunohistochemical study of 39 cases
3. Non-small cell lung cancer: Clinical value of new biological predictors
4. The biology of lung cancer
5. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma
6. Cellular predictive factors for the drug response of lung cancer
7. Predictive molecular markers in non-small cell lung cancer
8. Overexpression of P-glycoprotein and glutathione S-transferase-π in resistant non-small cell lung carcinomas of smokers
9. DNA distribution in non-small cell lung carcinomas and its relationship to clinical behaviour
10. Apoptosis in non-small cell lung cancer as related to drug resistance and prognosis
11. Protooncogene fos: A multifaceted gene
12. Fos-associated cellular p39 is related to nuclear transcription factor AP-1
13. Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas
14. The pathway to signal achievement
15. Ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent
16. Prognostic significance of the expression of ras oncogene product in non-small cell lung cancer
17. P53-dependent apoptosis pathway
18. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer
19. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small cell lung cancer
20. Expression of p53 oncoprotein in non-small cell lung cancer: A favorable prognostic factor
21. P53 in non-small cell lung cancer
22. Immunohistochemical detection of p53 in non-small cell lung cancer
23. Epidermal growth factor and its receptor
24. Epidermal growth factor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression
25. Prognostic significance of the expression of c-fos, c-jun, and c-erbB-1 oncogene products in human squamous cell lung carcinomas
26. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
27. Regulation of apoptosis in the immune system
28. Evidence that Fas-induced apoptosis leads to S phase arrest
29. Fas expression in non-small cell lung cancer: Its prognostic effect in completely resected stage III patients
30. Expression of Fas (CD95/APO-1) and Fas ligand in lung cancer, its prognostic and predictive relevance
31. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived haemopoietic cell lines
32. Bcl-2 functions in an antioxidant pathway to prevent apoptosis
33. Bcl-2 protein in non-small cell lung carcinoma
34. Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma
35. Thymidine labelling index as prognostic factor in resected non-small cell lung cancer
36. Prognostic role of proliferating cell nuclear antigen in lung cancer: An immunohistochemical analysis
37. Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer
38. Messenger RNA expression of resistance factors and their correlation to the proliferative activity in childhood acute lymphoblastic leukemia
39. Increased thymidylate synthase protein levels are principally associated with proliferation but not cell cycle phase in asynchronous human cancer cells
40. Kip1, a cyclin-dependent kinase inhibitor, during G1/S transition